Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Demand and Key Producers, 2022-2028
The Kidney Injury Molecule 1 (KIM-1) ELISA Kit quantifies KIM-1 concentrations in serum, plasma, and other biological fluids.
This report studies the global Kidney Injury Molecule 1 (KIM-1) ELISA Kit production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Kidney Injury Molecule 1 (KIM-1) ELISA Kit, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Kidney Injury Molecule 1 (KIM-1) ELISA Kit that contribute to its increasing demand across many markets.
The global Kidney Injury Molecule 1 (KIM-1) ELISA Kit market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit total production and demand, 2017-2028, (K Units)
Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit total production value, 2017-2028, (USD Million)
Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit domestic production, consumption, key domestic manufacturers and share
Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Kidney Injury Molecule 1 (KIM-1) ELISA Kit market based on the following parameters – headquarters, production locations, products portfolio, Kidney Injury Molecule 1 (KIM-1) ELISA Kit revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Kidney Injury Molecule 1 (KIM-1) ELISA Kit market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market, By Region:
1. How big is the global Kidney Injury Molecule 1 (KIM-1) ELISA Kit market?
2. What is the demand of the global Kidney Injury Molecule 1 (KIM-1) ELISA Kit market?
3. What is the year over year growth of the global Kidney Injury Molecule 1 (KIM-1) ELISA Kit market?
4. What is the production and production value of the global Kidney Injury Molecule 1 (KIM-1) ELISA Kit market?
5. Who are the key producers in the global Kidney Injury Molecule 1 (KIM-1) ELISA Kit market?
6. What are the growth factors driving the market demand?
This report studies the global Kidney Injury Molecule 1 (KIM-1) ELISA Kit production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Kidney Injury Molecule 1 (KIM-1) ELISA Kit, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Kidney Injury Molecule 1 (KIM-1) ELISA Kit that contribute to its increasing demand across many markets.
The global Kidney Injury Molecule 1 (KIM-1) ELISA Kit market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit total production and demand, 2017-2028, (K Units)
Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit total production value, 2017-2028, (USD Million)
Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit domestic production, consumption, key domestic manufacturers and share
Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Kidney Injury Molecule 1 (KIM-1) ELISA Kit market based on the following parameters – headquarters, production locations, products portfolio, Kidney Injury Molecule 1 (KIM-1) ELISA Kit revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Kidney Injury Molecule 1 (KIM-1) ELISA Kit market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Human
- Mouse
- Rat
- Porcine
- Other
- Hospital
- Research Institute
- Other
- Elabscience Biotechnology Inc.
- Crystal Chem
- Wuhan Fine Biotech Co., Ltd.
- MyBiosource, Inc.
- Shanghai Korain Biotech Co., Ltd.
- ??Abcam
- Enzo Life Sciences, Inc.
- CUSABIO
- CLOUD-CLONE CORP.
- Creative Diagnostics
- Bio-Techne
- Innovative Research
- RayBiotech, Inc.
- Assay Genie
- Cepham Life Sciences, Inc
- Abbexa
- Geno Technology, Inc.
- ZodelBiotec Ltd.
1. How big is the global Kidney Injury Molecule 1 (KIM-1) ELISA Kit market?
2. What is the demand of the global Kidney Injury Molecule 1 (KIM-1) ELISA Kit market?
3. What is the year over year growth of the global Kidney Injury Molecule 1 (KIM-1) ELISA Kit market?
4. What is the production and production value of the global Kidney Injury Molecule 1 (KIM-1) ELISA Kit market?
5. Who are the key producers in the global Kidney Injury Molecule 1 (KIM-1) ELISA Kit market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Introduction
1.2 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Supply & Forecast
1.2.1 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value (2017 & 2021 & 2028)
1.2.2 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (2017-2028)
1.2.3 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Pricing Trends (2017-2028)
1.3 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Region
1.3.1 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Region (2017-2028)
1.3.2 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Region (2017-2028)
1.3.3 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Region (2017-2028)
1.3.4 North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (2017-2028)
1.3.5 Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (2017-2028)
1.3.6 China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (2017-2028)
1.3.7 Japan Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Demand (2017-2028)
2.2 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption by Region
2.2.1 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption by Region (2017-2022)
2.2.2 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption Forecast by Region (2023-2028)
2.3 United States Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028)
2.4 China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028)
2.5 Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028)
2.6 Japan Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028)
2.7 South Korea Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028)
2.8 ASEAN Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028)
2.9 India Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028)
3 WORLD KIDNEY INJURY MOLECULE 1 (KIM-1) ELISA KIT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Manufacturer (2017-2022)
3.2 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Manufacturer (2017-2022)
3.3 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Manufacturer (2017-2022)
3.4 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Kidney Injury Molecule 1 (KIM-1) ELISA Kit in 2021
3.5.3 Global Concentration Ratios (CR8) for Kidney Injury Molecule 1 (KIM-1) ELISA Kit in 2021
3.6 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market: Overall Company Footprint Analysis
3.6.1 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market: Region Footprint
3.6.2 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market: Company Product Type Footprint
3.6.3 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Comparison
4.1.1 United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Comparison
4.2.1 United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption Comparison
4.3.1 United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Kidney Injury Molecule 1 (KIM-1) ELISA Kit Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Domestic Manufacturer, (2017-2022)
4.5 China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Human
5.2.2 Mouse
5.2.3 Rat
5.2.4 Porcine
5.2.5 Other
5.3 Market Segment by Type
5.3.1 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Type (2017-2028)
5.3.2 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Type (2017-2028)
5.3.3 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Research Institute
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Application (2017-2028)
6.3.2 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Application (2017-2028)
6.3.3 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Elabscience Biotechnology Inc.
7.1.1 Elabscience Biotechnology Inc. Details
7.1.2 Elabscience Biotechnology Inc. Major Business
7.1.3 Elabscience Biotechnology Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.1.4 Elabscience Biotechnology Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Elabscience Biotechnology Inc. Recent Developments/Updates
7.1.6 Elabscience Biotechnology Inc. Competitive Strengths & Weaknesses
7.2 Crystal Chem
7.2.1 Crystal Chem Details
7.2.2 Crystal Chem Major Business
7.2.3 Crystal Chem Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.2.4 Crystal Chem Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Crystal Chem Recent Developments/Updates
7.2.6 Crystal Chem Competitive Strengths & Weaknesses
7.3 Wuhan Fine Biotech Co., Ltd.
7.3.1 Wuhan Fine Biotech Co., Ltd. Details
7.3.2 Wuhan Fine Biotech Co., Ltd. Major Business
7.3.3 Wuhan Fine Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.3.4 Wuhan Fine Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
7.3.6 Wuhan Fine Biotech Co., Ltd. Competitive Strengths & Weaknesses
7.4 MyBiosource, Inc.
7.4.1 MyBiosource, Inc. Details
7.4.2 MyBiosource, Inc. Major Business
7.4.3 MyBiosource, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.4.4 MyBiosource, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 MyBiosource, Inc. Recent Developments/Updates
7.4.6 MyBiosource, Inc. Competitive Strengths & Weaknesses
7.5 Shanghai Korain Biotech Co., Ltd.
7.5.1 Shanghai Korain Biotech Co., Ltd. Details
7.5.2 Shanghai Korain Biotech Co., Ltd. Major Business
7.5.3 Shanghai Korain Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.5.4 Shanghai Korain Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Shanghai Korain Biotech Co., Ltd. Recent Developments/Updates
7.5.6 Shanghai Korain Biotech Co., Ltd. Competitive Strengths & Weaknesses
7.6 ??Abcam
7.6.1 ??Abcam Details
7.6.2 ??Abcam Major Business
7.6.3 ??Abcam Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.6.4 ??Abcam Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 ??Abcam Recent Developments/Updates
7.6.6 ??Abcam Competitive Strengths & Weaknesses
7.7 Enzo Life Sciences, Inc.
7.7.1 Enzo Life Sciences, Inc. Details
7.7.2 Enzo Life Sciences, Inc. Major Business
7.7.3 Enzo Life Sciences, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.7.4 Enzo Life Sciences, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Enzo Life Sciences, Inc. Recent Developments/Updates
7.7.6 Enzo Life Sciences, Inc. Competitive Strengths & Weaknesses
7.8 CUSABIO
7.8.1 CUSABIO Details
7.8.2 CUSABIO Major Business
7.8.3 CUSABIO Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.8.4 CUSABIO Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 CUSABIO Recent Developments/Updates
7.8.6 CUSABIO Competitive Strengths & Weaknesses
7.9 CLOUD-CLONE CORP.
7.9.1 CLOUD-CLONE CORP. Details
7.9.2 CLOUD-CLONE CORP. Major Business
7.9.3 CLOUD-CLONE CORP. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.9.4 CLOUD-CLONE CORP. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 CLOUD-CLONE CORP. Recent Developments/Updates
7.9.6 CLOUD-CLONE CORP. Competitive Strengths & Weaknesses
7.10 Creative Diagnostics
7.10.1 Creative Diagnostics Details
7.10.2 Creative Diagnostics Major Business
7.10.3 Creative Diagnostics Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.10.4 Creative Diagnostics Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Creative Diagnostics Recent Developments/Updates
7.10.6 Creative Diagnostics Competitive Strengths & Weaknesses
7.11 Bio-Techne
7.11.1 Bio-Techne Details
7.11.2 Bio-Techne Major Business
7.11.3 Bio-Techne Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.11.4 Bio-Techne Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Bio-Techne Recent Developments/Updates
7.11.6 Bio-Techne Competitive Strengths & Weaknesses
7.12 Innovative Research
7.12.1 Innovative Research Details
7.12.2 Innovative Research Major Business
7.12.3 Innovative Research Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.12.4 Innovative Research Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Innovative Research Recent Developments/Updates
7.12.6 Innovative Research Competitive Strengths & Weaknesses
7.13 RayBiotech, Inc.
7.13.1 RayBiotech, Inc. Details
7.13.2 RayBiotech, Inc. Major Business
7.13.3 RayBiotech, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.13.4 RayBiotech, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 RayBiotech, Inc. Recent Developments/Updates
7.13.6 RayBiotech, Inc. Competitive Strengths & Weaknesses
7.14 Assay Genie
7.14.1 Assay Genie Details
7.14.2 Assay Genie Major Business
7.14.3 Assay Genie Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.14.4 Assay Genie Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Assay Genie Recent Developments/Updates
7.14.6 Assay Genie Competitive Strengths & Weaknesses
7.15 Cepham Life Sciences, Inc
7.15.1 Cepham Life Sciences, Inc Details
7.15.2 Cepham Life Sciences, Inc Major Business
7.15.3 Cepham Life Sciences, Inc Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.15.4 Cepham Life Sciences, Inc Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Cepham Life Sciences, Inc Recent Developments/Updates
7.15.6 Cepham Life Sciences, Inc Competitive Strengths & Weaknesses
7.16 Abbexa
7.16.1 Abbexa Details
7.16.2 Abbexa Major Business
7.16.3 Abbexa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.16.4 Abbexa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Abbexa Recent Developments/Updates
7.16.6 Abbexa Competitive Strengths & Weaknesses
7.17 Geno Technology, Inc.
7.17.1 Geno Technology, Inc. Details
7.17.2 Geno Technology, Inc. Major Business
7.17.3 Geno Technology, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.17.4 Geno Technology, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Geno Technology, Inc. Recent Developments/Updates
7.17.6 Geno Technology, Inc. Competitive Strengths & Weaknesses
7.18 ZodelBiotec Ltd.
7.18.1 ZodelBiotec Ltd. Details
7.18.2 ZodelBiotec Ltd. Major Business
7.18.3 ZodelBiotec Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.18.4 ZodelBiotec Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 ZodelBiotec Ltd. Recent Developments/Updates
7.18.6 ZodelBiotec Ltd. Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Kidney Injury Molecule 1 (KIM-1) ELISA Kit and Key Manufacturers
8.2 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Manufacturing Costs
8.3 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Process
8.4 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Kidney Injury Molecule 1 (KIM-1) ELISA Kit Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Typical Distributors
9.3 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Introduction
1.2 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Supply & Forecast
1.2.1 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value (2017 & 2021 & 2028)
1.2.2 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (2017-2028)
1.2.3 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Pricing Trends (2017-2028)
1.3 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Region
1.3.1 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Region (2017-2028)
1.3.2 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Region (2017-2028)
1.3.3 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Region (2017-2028)
1.3.4 North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (2017-2028)
1.3.5 Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (2017-2028)
1.3.6 China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (2017-2028)
1.3.7 Japan Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Demand (2017-2028)
2.2 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption by Region
2.2.1 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption by Region (2017-2022)
2.2.2 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption Forecast by Region (2023-2028)
2.3 United States Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028)
2.4 China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028)
2.5 Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028)
2.6 Japan Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028)
2.7 South Korea Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028)
2.8 ASEAN Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028)
2.9 India Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028)
3 WORLD KIDNEY INJURY MOLECULE 1 (KIM-1) ELISA KIT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Manufacturer (2017-2022)
3.2 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Manufacturer (2017-2022)
3.3 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Manufacturer (2017-2022)
3.4 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Kidney Injury Molecule 1 (KIM-1) ELISA Kit in 2021
3.5.3 Global Concentration Ratios (CR8) for Kidney Injury Molecule 1 (KIM-1) ELISA Kit in 2021
3.6 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market: Overall Company Footprint Analysis
3.6.1 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market: Region Footprint
3.6.2 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market: Company Product Type Footprint
3.6.3 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Comparison
4.1.1 United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Comparison
4.2.1 United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption Comparison
4.3.1 United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Kidney Injury Molecule 1 (KIM-1) ELISA Kit Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Domestic Manufacturer, (2017-2022)
4.5 China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Human
5.2.2 Mouse
5.2.3 Rat
5.2.4 Porcine
5.2.5 Other
5.3 Market Segment by Type
5.3.1 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Type (2017-2028)
5.3.2 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Type (2017-2028)
5.3.3 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Research Institute
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Application (2017-2028)
6.3.2 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Application (2017-2028)
6.3.3 World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Elabscience Biotechnology Inc.
7.1.1 Elabscience Biotechnology Inc. Details
7.1.2 Elabscience Biotechnology Inc. Major Business
7.1.3 Elabscience Biotechnology Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.1.4 Elabscience Biotechnology Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Elabscience Biotechnology Inc. Recent Developments/Updates
7.1.6 Elabscience Biotechnology Inc. Competitive Strengths & Weaknesses
7.2 Crystal Chem
7.2.1 Crystal Chem Details
7.2.2 Crystal Chem Major Business
7.2.3 Crystal Chem Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.2.4 Crystal Chem Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Crystal Chem Recent Developments/Updates
7.2.6 Crystal Chem Competitive Strengths & Weaknesses
7.3 Wuhan Fine Biotech Co., Ltd.
7.3.1 Wuhan Fine Biotech Co., Ltd. Details
7.3.2 Wuhan Fine Biotech Co., Ltd. Major Business
7.3.3 Wuhan Fine Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.3.4 Wuhan Fine Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
7.3.6 Wuhan Fine Biotech Co., Ltd. Competitive Strengths & Weaknesses
7.4 MyBiosource, Inc.
7.4.1 MyBiosource, Inc. Details
7.4.2 MyBiosource, Inc. Major Business
7.4.3 MyBiosource, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.4.4 MyBiosource, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 MyBiosource, Inc. Recent Developments/Updates
7.4.6 MyBiosource, Inc. Competitive Strengths & Weaknesses
7.5 Shanghai Korain Biotech Co., Ltd.
7.5.1 Shanghai Korain Biotech Co., Ltd. Details
7.5.2 Shanghai Korain Biotech Co., Ltd. Major Business
7.5.3 Shanghai Korain Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.5.4 Shanghai Korain Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Shanghai Korain Biotech Co., Ltd. Recent Developments/Updates
7.5.6 Shanghai Korain Biotech Co., Ltd. Competitive Strengths & Weaknesses
7.6 ??Abcam
7.6.1 ??Abcam Details
7.6.2 ??Abcam Major Business
7.6.3 ??Abcam Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.6.4 ??Abcam Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 ??Abcam Recent Developments/Updates
7.6.6 ??Abcam Competitive Strengths & Weaknesses
7.7 Enzo Life Sciences, Inc.
7.7.1 Enzo Life Sciences, Inc. Details
7.7.2 Enzo Life Sciences, Inc. Major Business
7.7.3 Enzo Life Sciences, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.7.4 Enzo Life Sciences, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Enzo Life Sciences, Inc. Recent Developments/Updates
7.7.6 Enzo Life Sciences, Inc. Competitive Strengths & Weaknesses
7.8 CUSABIO
7.8.1 CUSABIO Details
7.8.2 CUSABIO Major Business
7.8.3 CUSABIO Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.8.4 CUSABIO Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 CUSABIO Recent Developments/Updates
7.8.6 CUSABIO Competitive Strengths & Weaknesses
7.9 CLOUD-CLONE CORP.
7.9.1 CLOUD-CLONE CORP. Details
7.9.2 CLOUD-CLONE CORP. Major Business
7.9.3 CLOUD-CLONE CORP. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.9.4 CLOUD-CLONE CORP. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 CLOUD-CLONE CORP. Recent Developments/Updates
7.9.6 CLOUD-CLONE CORP. Competitive Strengths & Weaknesses
7.10 Creative Diagnostics
7.10.1 Creative Diagnostics Details
7.10.2 Creative Diagnostics Major Business
7.10.3 Creative Diagnostics Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.10.4 Creative Diagnostics Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Creative Diagnostics Recent Developments/Updates
7.10.6 Creative Diagnostics Competitive Strengths & Weaknesses
7.11 Bio-Techne
7.11.1 Bio-Techne Details
7.11.2 Bio-Techne Major Business
7.11.3 Bio-Techne Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.11.4 Bio-Techne Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Bio-Techne Recent Developments/Updates
7.11.6 Bio-Techne Competitive Strengths & Weaknesses
7.12 Innovative Research
7.12.1 Innovative Research Details
7.12.2 Innovative Research Major Business
7.12.3 Innovative Research Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.12.4 Innovative Research Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Innovative Research Recent Developments/Updates
7.12.6 Innovative Research Competitive Strengths & Weaknesses
7.13 RayBiotech, Inc.
7.13.1 RayBiotech, Inc. Details
7.13.2 RayBiotech, Inc. Major Business
7.13.3 RayBiotech, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.13.4 RayBiotech, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 RayBiotech, Inc. Recent Developments/Updates
7.13.6 RayBiotech, Inc. Competitive Strengths & Weaknesses
7.14 Assay Genie
7.14.1 Assay Genie Details
7.14.2 Assay Genie Major Business
7.14.3 Assay Genie Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.14.4 Assay Genie Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Assay Genie Recent Developments/Updates
7.14.6 Assay Genie Competitive Strengths & Weaknesses
7.15 Cepham Life Sciences, Inc
7.15.1 Cepham Life Sciences, Inc Details
7.15.2 Cepham Life Sciences, Inc Major Business
7.15.3 Cepham Life Sciences, Inc Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.15.4 Cepham Life Sciences, Inc Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Cepham Life Sciences, Inc Recent Developments/Updates
7.15.6 Cepham Life Sciences, Inc Competitive Strengths & Weaknesses
7.16 Abbexa
7.16.1 Abbexa Details
7.16.2 Abbexa Major Business
7.16.3 Abbexa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.16.4 Abbexa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Abbexa Recent Developments/Updates
7.16.6 Abbexa Competitive Strengths & Weaknesses
7.17 Geno Technology, Inc.
7.17.1 Geno Technology, Inc. Details
7.17.2 Geno Technology, Inc. Major Business
7.17.3 Geno Technology, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.17.4 Geno Technology, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Geno Technology, Inc. Recent Developments/Updates
7.17.6 Geno Technology, Inc. Competitive Strengths & Weaknesses
7.18 ZodelBiotec Ltd.
7.18.1 ZodelBiotec Ltd. Details
7.18.2 ZodelBiotec Ltd. Major Business
7.18.3 ZodelBiotec Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
7.18.4 ZodelBiotec Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 ZodelBiotec Ltd. Recent Developments/Updates
7.18.6 ZodelBiotec Ltd. Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Kidney Injury Molecule 1 (KIM-1) ELISA Kit and Key Manufacturers
8.2 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Manufacturing Costs
8.3 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Process
8.4 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Kidney Injury Molecule 1 (KIM-1) ELISA Kit Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Typical Distributors
9.3 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Region (2017-2022) & (USD Million)
Table 3. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Region (2023-2028) & (USD Million)
Table 4. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share by Region (2017-2022)
Table 5. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share by Region (2023-2028)
Table 6. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Region (2017-2022) & (K Units)
Table 7. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Region (2023-2028) & (K Units)
Table 8. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Market Share by Region (2017-2022)
Table 9. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Market Share by Region (2023-2028)
Table 10. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Major Market Trends
Table 13. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption by Region (2017-2022) & (K Units)
Table 15. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Kidney Injury Molecule 1 (KIM-1) ELISA Kit Producers in 2021
Table 18. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Kidney Injury Molecule 1 (KIM-1) ELISA Kit Producers in 2021
Table 20. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Company Evaluation Quadrant
Table 22. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Site of Key Manufacturer
Table 24. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market: Company Product Type Footprint
Table 25. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market: Company Product Application Footprint
Table 26. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Competitive Factors
Table 27. Kidney Injury Molecule 1 (KIM-1) ELISA Kit New Entrant and Capacity Expansion Plans
Table 28. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Mergers & Acquisitions Activity
Table 29. United States VS China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Type (2017-2022) & (K Units)
Table 49. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Type (2023-2028) & (K Units)
Table 50. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Type (2017-2022) & (USD Million)
Table 51. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Type (2023-2028) & (USD Million)
Table 52. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Application (2017-2022) & (K Units)
Table 56. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Application (2023-2028) & (K Units)
Table 57. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Application (2017-2022) & (USD Million)
Table 58. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Application (2023-2028) & (USD Million)
Table 59. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Elabscience Biotechnology Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Elabscience Biotechnology Inc. Major Business
Table 63. Elabscience Biotechnology Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 64. Elabscience Biotechnology Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Elabscience Biotechnology Inc. Recent Developments/Updates
Table 66. Elabscience Biotechnology Inc. Competitive Strengths & Weaknesses
Table 67. Crystal Chem Basic Information, Manufacturing Base and Competitors
Table 68. Crystal Chem Major Business
Table 69. Crystal Chem Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 70. Crystal Chem Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Crystal Chem Recent Developments/Updates
Table 72. Crystal Chem Competitive Strengths & Weaknesses
Table 73. Wuhan Fine Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 74. Wuhan Fine Biotech Co., Ltd. Major Business
Table 75. Wuhan Fine Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 76. Wuhan Fine Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
Table 78. Wuhan Fine Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 79. MyBiosource, Inc. Basic Information, Manufacturing Base and Competitors
Table 80. MyBiosource, Inc. Major Business
Table 81. MyBiosource, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 82. MyBiosource, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. MyBiosource, Inc. Recent Developments/Updates
Table 84. MyBiosource, Inc. Competitive Strengths & Weaknesses
Table 85. Shanghai Korain Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 86. Shanghai Korain Biotech Co., Ltd. Major Business
Table 87. Shanghai Korain Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 88. Shanghai Korain Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Shanghai Korain Biotech Co., Ltd. Recent Developments/Updates
Table 90. Shanghai Korain Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 91. ??Abcam Basic Information, Manufacturing Base and Competitors
Table 92. ??Abcam Major Business
Table 93. ??Abcam Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 94. ??Abcam Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. ??Abcam Recent Developments/Updates
Table 96. ??Abcam Competitive Strengths & Weaknesses
Table 97. Enzo Life Sciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 98. Enzo Life Sciences, Inc. Major Business
Table 99. Enzo Life Sciences, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 100. Enzo Life Sciences, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Enzo Life Sciences, Inc. Recent Developments/Updates
Table 102. Enzo Life Sciences, Inc. Competitive Strengths & Weaknesses
Table 103. CUSABIO Basic Information, Manufacturing Base and Competitors
Table 104. CUSABIO Major Business
Table 105. CUSABIO Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 106. CUSABIO Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. CUSABIO Recent Developments/Updates
Table 108. CUSABIO Competitive Strengths & Weaknesses
Table 109. CLOUD-CLONE CORP. Basic Information, Manufacturing Base and Competitors
Table 110. CLOUD-CLONE CORP. Major Business
Table 111. CLOUD-CLONE CORP. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 112. CLOUD-CLONE CORP. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. CLOUD-CLONE CORP. Recent Developments/Updates
Table 114. CLOUD-CLONE CORP. Competitive Strengths & Weaknesses
Table 115. Creative Diagnostics Basic Information, Manufacturing Base and Competitors
Table 116. Creative Diagnostics Major Business
Table 117. Creative Diagnostics Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 118. Creative Diagnostics Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Creative Diagnostics Recent Developments/Updates
Table 120. Creative Diagnostics Competitive Strengths & Weaknesses
Table 121. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 122. Bio-Techne Major Business
Table 123. Bio-Techne Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 124. Bio-Techne Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Bio-Techne Recent Developments/Updates
Table 126. Bio-Techne Competitive Strengths & Weaknesses
Table 127. Innovative Research Basic Information, Manufacturing Base and Competitors
Table 128. Innovative Research Major Business
Table 129. Innovative Research Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 130. Innovative Research Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Innovative Research Recent Developments/Updates
Table 132. Innovative Research Competitive Strengths & Weaknesses
Table 133. RayBiotech, Inc. Basic Information, Manufacturing Base and Competitors
Table 134. RayBiotech, Inc. Major Business
Table 135. RayBiotech, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 136. RayBiotech, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. RayBiotech, Inc. Recent Developments/Updates
Table 138. RayBiotech, Inc. Competitive Strengths & Weaknesses
Table 139. Assay Genie Basic Information, Manufacturing Base and Competitors
Table 140. Assay Genie Major Business
Table 141. Assay Genie Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 142. Assay Genie Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Assay Genie Recent Developments/Updates
Table 144. Assay Genie Competitive Strengths & Weaknesses
Table 145. Cepham Life Sciences, Inc Basic Information, Manufacturing Base and Competitors
Table 146. Cepham Life Sciences, Inc Major Business
Table 147. Cepham Life Sciences, Inc Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 148. Cepham Life Sciences, Inc Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Cepham Life Sciences, Inc Recent Developments/Updates
Table 150. Cepham Life Sciences, Inc Competitive Strengths & Weaknesses
Table 151. Abbexa Basic Information, Manufacturing Base and Competitors
Table 152. Abbexa Major Business
Table 153. Abbexa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 154. Abbexa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Abbexa Recent Developments/Updates
Table 156. Abbexa Competitive Strengths & Weaknesses
Table 157. Geno Technology, Inc. Basic Information, Manufacturing Base and Competitors
Table 158. Geno Technology, Inc. Major Business
Table 159. Geno Technology, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 160. Geno Technology, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. Geno Technology, Inc. Recent Developments/Updates
Table 162. ZodelBiotec Ltd. Basic Information, Manufacturing Base and Competitors
Table 163. ZodelBiotec Ltd. Major Business
Table 164. ZodelBiotec Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 165. ZodelBiotec Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 166. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Raw Material
Table 167. Key Manufacturers of Kidney Injury Molecule 1 (KIM-1) ELISA Kit Raw Materials
Table 168. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Typical Distributors
Table 169. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Typical Customers
Table 1. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Region (2017-2022) & (USD Million)
Table 3. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Region (2023-2028) & (USD Million)
Table 4. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share by Region (2017-2022)
Table 5. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share by Region (2023-2028)
Table 6. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Region (2017-2022) & (K Units)
Table 7. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Region (2023-2028) & (K Units)
Table 8. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Market Share by Region (2017-2022)
Table 9. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Market Share by Region (2023-2028)
Table 10. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Major Market Trends
Table 13. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption by Region (2017-2022) & (K Units)
Table 15. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Kidney Injury Molecule 1 (KIM-1) ELISA Kit Producers in 2021
Table 18. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Kidney Injury Molecule 1 (KIM-1) ELISA Kit Producers in 2021
Table 20. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Company Evaluation Quadrant
Table 22. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Site of Key Manufacturer
Table 24. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market: Company Product Type Footprint
Table 25. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market: Company Product Application Footprint
Table 26. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Competitive Factors
Table 27. Kidney Injury Molecule 1 (KIM-1) ELISA Kit New Entrant and Capacity Expansion Plans
Table 28. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Mergers & Acquisitions Activity
Table 29. United States VS China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Type (2017-2022) & (K Units)
Table 49. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Type (2023-2028) & (K Units)
Table 50. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Type (2017-2022) & (USD Million)
Table 51. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Type (2023-2028) & (USD Million)
Table 52. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Application (2017-2022) & (K Units)
Table 56. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production by Application (2023-2028) & (K Units)
Table 57. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Application (2017-2022) & (USD Million)
Table 58. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Application (2023-2028) & (USD Million)
Table 59. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Elabscience Biotechnology Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Elabscience Biotechnology Inc. Major Business
Table 63. Elabscience Biotechnology Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 64. Elabscience Biotechnology Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Elabscience Biotechnology Inc. Recent Developments/Updates
Table 66. Elabscience Biotechnology Inc. Competitive Strengths & Weaknesses
Table 67. Crystal Chem Basic Information, Manufacturing Base and Competitors
Table 68. Crystal Chem Major Business
Table 69. Crystal Chem Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 70. Crystal Chem Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Crystal Chem Recent Developments/Updates
Table 72. Crystal Chem Competitive Strengths & Weaknesses
Table 73. Wuhan Fine Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 74. Wuhan Fine Biotech Co., Ltd. Major Business
Table 75. Wuhan Fine Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 76. Wuhan Fine Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
Table 78. Wuhan Fine Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 79. MyBiosource, Inc. Basic Information, Manufacturing Base and Competitors
Table 80. MyBiosource, Inc. Major Business
Table 81. MyBiosource, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 82. MyBiosource, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. MyBiosource, Inc. Recent Developments/Updates
Table 84. MyBiosource, Inc. Competitive Strengths & Weaknesses
Table 85. Shanghai Korain Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 86. Shanghai Korain Biotech Co., Ltd. Major Business
Table 87. Shanghai Korain Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 88. Shanghai Korain Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Shanghai Korain Biotech Co., Ltd. Recent Developments/Updates
Table 90. Shanghai Korain Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 91. ??Abcam Basic Information, Manufacturing Base and Competitors
Table 92. ??Abcam Major Business
Table 93. ??Abcam Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 94. ??Abcam Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. ??Abcam Recent Developments/Updates
Table 96. ??Abcam Competitive Strengths & Weaknesses
Table 97. Enzo Life Sciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 98. Enzo Life Sciences, Inc. Major Business
Table 99. Enzo Life Sciences, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 100. Enzo Life Sciences, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Enzo Life Sciences, Inc. Recent Developments/Updates
Table 102. Enzo Life Sciences, Inc. Competitive Strengths & Weaknesses
Table 103. CUSABIO Basic Information, Manufacturing Base and Competitors
Table 104. CUSABIO Major Business
Table 105. CUSABIO Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 106. CUSABIO Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. CUSABIO Recent Developments/Updates
Table 108. CUSABIO Competitive Strengths & Weaknesses
Table 109. CLOUD-CLONE CORP. Basic Information, Manufacturing Base and Competitors
Table 110. CLOUD-CLONE CORP. Major Business
Table 111. CLOUD-CLONE CORP. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 112. CLOUD-CLONE CORP. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. CLOUD-CLONE CORP. Recent Developments/Updates
Table 114. CLOUD-CLONE CORP. Competitive Strengths & Weaknesses
Table 115. Creative Diagnostics Basic Information, Manufacturing Base and Competitors
Table 116. Creative Diagnostics Major Business
Table 117. Creative Diagnostics Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 118. Creative Diagnostics Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Creative Diagnostics Recent Developments/Updates
Table 120. Creative Diagnostics Competitive Strengths & Weaknesses
Table 121. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 122. Bio-Techne Major Business
Table 123. Bio-Techne Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 124. Bio-Techne Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Bio-Techne Recent Developments/Updates
Table 126. Bio-Techne Competitive Strengths & Weaknesses
Table 127. Innovative Research Basic Information, Manufacturing Base and Competitors
Table 128. Innovative Research Major Business
Table 129. Innovative Research Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 130. Innovative Research Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Innovative Research Recent Developments/Updates
Table 132. Innovative Research Competitive Strengths & Weaknesses
Table 133. RayBiotech, Inc. Basic Information, Manufacturing Base and Competitors
Table 134. RayBiotech, Inc. Major Business
Table 135. RayBiotech, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 136. RayBiotech, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. RayBiotech, Inc. Recent Developments/Updates
Table 138. RayBiotech, Inc. Competitive Strengths & Weaknesses
Table 139. Assay Genie Basic Information, Manufacturing Base and Competitors
Table 140. Assay Genie Major Business
Table 141. Assay Genie Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 142. Assay Genie Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Assay Genie Recent Developments/Updates
Table 144. Assay Genie Competitive Strengths & Weaknesses
Table 145. Cepham Life Sciences, Inc Basic Information, Manufacturing Base and Competitors
Table 146. Cepham Life Sciences, Inc Major Business
Table 147. Cepham Life Sciences, Inc Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 148. Cepham Life Sciences, Inc Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Cepham Life Sciences, Inc Recent Developments/Updates
Table 150. Cepham Life Sciences, Inc Competitive Strengths & Weaknesses
Table 151. Abbexa Basic Information, Manufacturing Base and Competitors
Table 152. Abbexa Major Business
Table 153. Abbexa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 154. Abbexa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Abbexa Recent Developments/Updates
Table 156. Abbexa Competitive Strengths & Weaknesses
Table 157. Geno Technology, Inc. Basic Information, Manufacturing Base and Competitors
Table 158. Geno Technology, Inc. Major Business
Table 159. Geno Technology, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 160. Geno Technology, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. Geno Technology, Inc. Recent Developments/Updates
Table 162. ZodelBiotec Ltd. Basic Information, Manufacturing Base and Competitors
Table 163. ZodelBiotec Ltd. Major Business
Table 164. ZodelBiotec Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product and Services
Table 165. ZodelBiotec Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 166. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Raw Material
Table 167. Key Manufacturers of Kidney Injury Molecule 1 (KIM-1) ELISA Kit Raw Materials
Table 168. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Typical Distributors
Table 169. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Typical Customers
LIST OF FIGURES
Figure 1. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Picture
Figure 2. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (2017-2028) & (K Units)
Figure 5. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price (2017-2028) & (US$/Unit)
Figure 6. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share by Region (2017-2028)
Figure 7. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Market Share by Region (2017-2028)
Figure 8. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (2017-2028) & (K Units)
Figure 9. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (2017-2028) & (K Units)
Figure 10. China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (2017-2028) & (K Units)
Figure 11. Japan Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (2017-2028) & (K Units)
Figure 12. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Demand (2017-2028) & (K Units)
Figure 15. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption Market Share by Region (2017-2028)
Figure 16. United States Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028) & (K Units)
Figure 17. China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028) & (K Units)
Figure 18. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028) & (K Units)
Figure 19. Japan Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028) & (K Units)
Figure 20. South Korea Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028) & (K Units)
Figure 22. India Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Kidney Injury Molecule 1 (KIM-1) ELISA Kit by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Kidney Injury Molecule 1 (KIM-1) ELISA Kit Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Kidney Injury Molecule 1 (KIM-1) ELISA Kit Markets in 2021
Figure 26. United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in United States
Figure 30. Key Producers and Market Share of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in China
Figure 31. Key Producers and Market Share of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in Rest of World
Figure 32. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share by Type in 2021
Figure 34. Human
Figure 35. Mouse
Figure 36. Rat
Figure 37. Porcine
Figure 38. Other
Figure 39. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Market Share by Type (2017-2028)
Figure 40. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share by Type (2017-2028)
Figure 41. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Type (2017-2028) & (US$/Unit)
Figure 42. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 43. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share by Application in 2021
Figure 44. Hospital
Figure 45. Research Institute
Figure 46. Other
Figure 47. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Market Share by Application (2017-2028)
Figure 48. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share by Application (2017-2028)
Figure 49. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Application (2017-2028) & (US$/Unit)
Figure 50. Manufacturing Cost Structure Analysis of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in 2021
Figure 51. Manufacturing Process Analysis of Kidney Injury Molecule 1 (KIM-1) ELISA Kit
Figure 52. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Industrial Chain
Figure 53. Distribution Channel Breakdown for Kidney Injury Molecule 1 (KIM-1) ELISA Kit Shipments (%): 2017-2028
Figure 54. Direct Channel Pros & Cons
Figure 55. Indirect Channel Pros & Cons
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Picture
Figure 2. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (2017-2028) & (K Units)
Figure 5. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price (2017-2028) & (US$/Unit)
Figure 6. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share by Region (2017-2028)
Figure 7. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Market Share by Region (2017-2028)
Figure 8. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (2017-2028) & (K Units)
Figure 9. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (2017-2028) & (K Units)
Figure 10. China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (2017-2028) & (K Units)
Figure 11. Japan Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production (2017-2028) & (K Units)
Figure 12. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Demand (2017-2028) & (K Units)
Figure 15. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption Market Share by Region (2017-2028)
Figure 16. United States Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028) & (K Units)
Figure 17. China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028) & (K Units)
Figure 18. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028) & (K Units)
Figure 19. Japan Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028) & (K Units)
Figure 20. South Korea Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028) & (K Units)
Figure 22. India Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Kidney Injury Molecule 1 (KIM-1) ELISA Kit by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Kidney Injury Molecule 1 (KIM-1) ELISA Kit Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Kidney Injury Molecule 1 (KIM-1) ELISA Kit Markets in 2021
Figure 26. United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Kidney Injury Molecule 1 (KIM-1) ELISA Kit Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in United States
Figure 30. Key Producers and Market Share of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in China
Figure 31. Key Producers and Market Share of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in Rest of World
Figure 32. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share by Type in 2021
Figure 34. Human
Figure 35. Mouse
Figure 36. Rat
Figure 37. Porcine
Figure 38. Other
Figure 39. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Market Share by Type (2017-2028)
Figure 40. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share by Type (2017-2028)
Figure 41. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Type (2017-2028) & (US$/Unit)
Figure 42. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 43. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share by Application in 2021
Figure 44. Hospital
Figure 45. Research Institute
Figure 46. Other
Figure 47. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Market Share by Application (2017-2028)
Figure 48. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Value Market Share by Application (2017-2028)
Figure 49. World Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Application (2017-2028) & (US$/Unit)
Figure 50. Manufacturing Cost Structure Analysis of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in 2021
Figure 51. Manufacturing Process Analysis of Kidney Injury Molecule 1 (KIM-1) ELISA Kit
Figure 52. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Industrial Chain
Figure 53. Distribution Channel Breakdown for Kidney Injury Molecule 1 (KIM-1) ELISA Kit Shipments (%): 2017-2028
Figure 54. Direct Channel Pros & Cons
Figure 55. Indirect Channel Pros & Cons
Figure 56. Methodology
Figure 57. Research Process and Data Source
